Literature DB >> 18614545

First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome.

Johannes Kapeller1, Lesley A Houghton, Hubert Mönnikes, Jutta Walstab, Dorothee Möller, Heinz Bönisch, Barbara Burwinkel, Frank Autschbach, Benjamin Funke, Felix Lasitschka, Nikolaus Gassler, Christine Fischer, Peter J Whorwell, Wendy Atkinson, Catherine Fell, Karl J Büchner, Marco Schmidtmann, Ivo van der Voort, Anna-Sophia Wisser, Thomas Berg, Gudrun Rappold, Beate Niesler.   

Abstract

Diarrhea predominant irritable bowel syndrome (IBS-D) is a complex disorder related to dysfunctions in the serotonergic system. As cis-regulatory variants can play a role in the etiology of complex conditions, we investigated the untranslated regions (UTRs) of the serotonin receptor type 3 subunit genes HTR3A and HTR3E. Mutation analysis was carried out in a pilot sample of 200 IBS patients and 100 healthy controls from the UK. The novel HTR3E 3'-UTR variant c.*76G>A (rs62625044) was associated with female IBS-D (P = 0.033, OR = 8.53). This association was confirmed in a replication study, including 119 IBS-D patients and 195 controls from Germany (P = 0.0046, OR = 4.92). Pooled analysis resulted in a highly significant association of c.*76G>A with female IBS-D (P = 0.0002, OR = 5.39). In a reporter assay, c.*76G>A affected binding of miR-510 to the HTR3E 3'-UTR and caused elevated luciferase expression. HTR3E and miR-510 co-localize in enterocytes of the gut epithelium as shown by in situ hybridization and RT-PCR. This is the first example indicating micro RNA-related expression regulation of a serotonin receptor gene with a cis-regulatory variant affecting this regulation and appearing to be associated with female IBS-D.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18614545     DOI: 10.1093/hmg/ddn195

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  88 in total

Review 1.  Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome.

Authors:  Michael Camilleri; David A Katzka
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-08       Impact factor: 4.052

Review 2.  The role of pharmacogenetics in nonmalignant gastrointestinal diseases.

Authors:  Michael Camilleri
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-07       Impact factor: 46.802

3.  Demonstrating polymorphic miRNA-mediated gene regulation in vivo: application to the g+6223G->A mutation of Texel sheep.

Authors:  Haruko Takeda; Carole Charlier; Frédéric Farnir; Michel Georges
Journal:  RNA       Date:  2010-08-02       Impact factor: 4.942

4.  MicroRNA polymorphisms: a giant leap towards personalized medicine.

Authors:  Prasun J Mishra
Journal:  Per Med       Date:  2009-03-01       Impact factor: 2.512

Review 5.  IBS: An epigenetic perspective.

Authors:  Timothy G Dinan; John Cryan; Fergus Shanahan; P W Napoleon Keeling; Eamonn M M Quigley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-06-29       Impact factor: 46.802

6.  Serotonin receptor diversity in the human colon: Expression of serotonin type 3 receptor subunits 5-HT3C, 5-HT3D, and 5-HT3E.

Authors:  Johannes Kapeller; Dorothee Möller; Felix Lasitschka; Frank Autschbach; Ruud Hovius; Gudrun Rappold; Michael Brüss; Michael D Gershon; Beate Niesler
Journal:  J Comp Neurol       Date:  2011-02-15       Impact factor: 3.215

7.  The HTR3A polymorphism c. -42C>T is associated with amygdala responsiveness in patients with irritable bowel syndrome.

Authors:  Lisa A Kilpatrick; Jennifer S Labus; Kristen Coveleskie; Christian Hammer; Gudrun Rappold; Kirsten Tillisch; Joshua A Bueller; Brandall Suyenobu; Johana M Jarcho; Jim A McRoberts; Beate Niesler; Emeran A Mayer
Journal:  Gastroenterology       Date:  2011-03-21       Impact factor: 22.682

Review 8.  Genetic approaches to functional gastrointestinal disorders.

Authors:  Yuri A Saito; Nandita Mitra; Emeran A Mayer
Journal:  Gastroenterology       Date:  2010-02-19       Impact factor: 22.682

9.  Challenges and prospects for pharmacotherapy in functional gastrointestinal disorders.

Authors:  Gareth J Sanger; Lin Chang; Chas Bountra; Lesley A Houghton
Journal:  Therap Adv Gastroenterol       Date:  2010-09       Impact factor: 4.409

Review 10.  MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine.

Authors:  Prasun J Mishra; Joseph R Bertino
Journal:  Pharmacogenomics       Date:  2009-03       Impact factor: 2.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.